Abstract
As data on the use of the latest-generation drugeluting stents (DES) in bifurcation interventions are lacking, we realized a multicenter registry to assess the procedural and clinical results obtained in patients with unselected bifurcated lesions treated with the novel zotarolimus-eluting Resolute stent (ZRS).
| Original language | English |
|---|---|
| Pages (from-to) | 50-54 |
| Number of pages | 5 |
| Journal | Journal of Invasive Cardiology |
| Volume | 23 |
| Publication status | Published - 2011 |
Keywords
- Aged
- Angioplasty, Balloon, Coronary
- Coronary Restenosis
- Coronary Stenosis
- Drug-Eluting Stents
- Female
- Follow-Up Studies
- Humans
- Incidence
- Italy
- Male
- Middle Aged
- Myocardial Infarction
- Registries
- Retrospective Studies
- Risk Factors
- Sirolimus
- Survival Rate
- Treatment Outcome
Fingerprint
Dive into the research topics of 'Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver